Tanaka Toshihiro

タナカトシヒロ | Tanaka Toshihiro

Affiliation and department：
Homepage URL (1)： http://www.med.fukuoka-u.ac.jp/interna1/index.php

Research field (5)： Tumor diagnostics and therapeutics , Healthcare management, medical sociology , Molecular biology , Tumor diagnostics and therapeutics , Hematology and oncology

Research keywords (11)： adenovirus vector , がん相談支援 , 腫瘍内科学 , Antibody therapy , Anti-cancer drug treatment , Breast cancer , Cancer immunity , Medical Oncology , Medical information science , 癌の遺伝子治療 , Development of antibody drugs against cancer

Research theme for competitive and other funds (7)：

2017 - 2019 EphA2およびEGFRを標的とした、がん薬物療法の開発
2015 - 2019 幹細胞選別及び評価チーム神経再生チーム
2010 - 2012 Pancreas-specific antibody production and development of pancreatic cancer therapy using virus vector
2008 - 2010 Study on the Usefulness of the Novel Tumor Marker MK-1 in the Diagnosis and Therapy of Cancer
2007 - 2009 膵癌標的化抗体を用いた遺伝子治療法の開発に関する研究

Show all

Papers (78)：

Yoshimi JOKO, Kumiko OHKUBO, Toshihiro TANAKA, Yoichiro YOSHIDA, Hiroyuki INOUE, Teppei YAMADA,Hiroshi, MATSUZAKI, Masamitsu KURAKAZU, Makoto HAMASAKI, Kazuki NABESHIMA, et al. Current Status and Efforts of Cancer Genomic Medicine at Fukuoka University Hospital: As the Cancer Genomic Medicine Coordinator. Med. Bull. Fukuoka Univ. 2022. 49. 2. 107-113
Kohjiro Mashino, Maki Tanaka, Miki Yamaguchi, Reiki Nishimura, Yutaka Yamamoto, Hiroaki Ueo, Toshihiro Tanaka, Kenichiro Koga, Tomoyuki Yoshiyama, Shoshu Mitsuyama, et al. Longitudinal efficacy and safety of capecitabine and cyclophosphamide as early-line treatment in patients with metastatic breast cancer: A prospective cohort study by the Kyushu Breast Cancer Study Group, Japan. Annals of Cancer Research and Therapy. 2022. 30. 1. 38-44
Toshihiro Tanaka, Rika Sakai, Ilseung Choi, Junichi Tsukada, Hidenori Sasaki, Yoshiko Naito, Fumiaki Kiyomi, Yasushi Takamatsu, Kazuo Tamura. Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma. Scientific Reports. 2022. 12. 1
Shigeto Maeda, Keisei Anan, Kenichiro Koga, Sayaka Kuba, Hiroshi Yano, Yuichiro Kai, Reiki Nishimura, Uhi Toh, Miki Yamaguchi, Kohjiro Mashino, et al. Baseline neutrophil-to-lymphocyte ratio and absolute lymphocyte count in patients with HER2-negative breast cancer treated with eribulin may predict overall survival. Journal of Clinical Oncology. 2021. 39. 15_suppl. e13005-e13005
Toshiki Maeda, Hidenori Sasaki, Atsushi Togawa, Toshihiro Tanaka, Hisatomi Arima, Tohru Takata, Yasushi Takamatsu. Surveillance of the current situation regarding influenza vaccination according to medical oncologists in Japan. Cancer Science. 2021. 112. 1. 433-443

ｍore...

MISC (31)：

佐々木秀法, 前田俊樹, 田中俊裕, 高田徹, 高田徹, 有馬久富, 高松泰. 外来がん薬物療法中の患者に対するインフルエンザワクチン接種に関する調査研究. 日本血液学会学術集会抄録(Web). 2020. 82nd
Reiki Nishimura, Uhi Toh, Maki Tanaka, Michiyo Saimura, Yasuhiro Okumura, Tsuyoshi Saito, Toshihiro Tanaka, Megumi Teraoka, Kazuo Shimada, Kazuhisa Katayama, et al. Correlation between HER2 related biomarkers (HER2, p95HER2, HER3, PTEN and PIK3CA) and treatment outcome of lapatinib plus capecitabine in HER2-positive metastatic breast cancer refractory to trastuzumab. JOURNAL OF CLINICAL ONCOLOGY. 2016. 34. 15
Yoichiro Yoshida, Masayasu Naito, Teppei Yamada, Naoya Aisu, Daibo Kojima, Toshiyuki Mera, Syu Tanimura, Toshihiro Tanaka, Keiko Naitoh, Kosei Yasumoto, et al. Clinical study on medical value of adoptive immunotherapy with chemotherapy for stage IV colorectal cancer (COMVI study). JOURNAL OF CLINICAL ONCOLOGY. 2016. 34. 4
Michinobu Yoshimura, Yosuke Ikari, Hiroo Katsuya, Atsushi Togawa, Toshitaka Goto, Toshihiro Tanaka, Kenji Ishitsuka, Tohru Takata, Yasushi Takamatsu, Kazuo Tamura. FEBRILE NEUTROPENIA(FN)AND D-INDEX. ANNALS OF ONCOLOGY. 2014. 25
Kentaro Ogata, Hiroo Katsuya, Akihiko Shirahashi, Yousuke Ikari, Michio Masaki, Toshitaka Goto, Toshihiro Tanaka, Kenji Ishitsuka, Yasushi Takamatsu, Kazuo Tamura. POLYPHARMACY IN ELDERLY CANCER PATIENTS. ANNALS OF ONCOLOGY. 2014. 25

ｍore...

Books (15)：

Medical Syndrome of Blood Disease 3rd edtion (V)
Nipponrinsho 2024
フローチャート抗がん薬副作用 : 対応の流れと治療のポイントがわかる
じほう 2020 ISBN:9784840752732
がん治療で起こる副作用・合併症の治療法と薬剤開発
技術情報協会 2018 ISBN:9784861047237
プロフェッショナルがんナーシング2017年6号トレンド☆エクスプレスいつものケアを見直そう! がん薬物療法の重大ニュース2017 これだけは
MCメディカ ISSN 2185-7318 2017
各領域専門医にきく乳癌薬物療法ケースファイル
南江堂 2014 ISBN:9784524266982

ｍore...

Lectures and oral presentations (75)：

膵管内乳頭粘液腺癌術後肺転移にぺムブロリズマブを投与した一例
(第120 回日本消化器病学会九州支部例会/第114 回日本消化器内視鏡学会九州支部例会 2022)
Current State and Satisfaction Surveys for User of Cancer Consultation Support Center at Fukuoka University Hospital.
(2022)
Baseline neutrophil-to-lymphocyte ratio and absolute lymphocyte count in patients with HER2-negative breast cancer treated with eribulin may predict overall survival.
(2021 ASCO Annual Meeting)
電子カルテアクセスログを利用した医師の活動状況の把握と勤務管理
(第22回日本医療マネジメント学会学術総会 2020)
中枢神経原発リンパ腫(PCNSL)に対する治療成績の後方視的検討
(第12回福岡県医学会総会 2020)

ｍore...

Education (2)：

1999 - 2003 Fukuoka University Graduate School, Division of Medicine
1988 - 1994 Fukuoka University Faculty of Medicine

Professional career (1)：

Doctor of Philosophy (Ph.D.) (Fukuoka University Graduate School of Medicine)

Awards (1)：

2006/09/27 - 日本分子腫瘍マーカー研究会第26回日本分子腫瘍マーカー研究会奨励賞

Association Membership(s) (8)：

Japan Society of Human Genetics , 日本医療マネジメント学会 , Japanese Breast Cancer Society , Japan Association for Medical Informatics , The Japanese Society of Internal Medicine , Japanese Society of Medical Oncology , 日本遺伝子治療学会 , Japanese Cancer Association

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page